Cargando…
A gene expression profile for the lower osteogenic potent of bone-derived MSCs from osteoporosis with T2DM and the potential mechanism
BACKGROUND: Osteoporosis (OP) patients complicated with type II diabetes mellitus (T2DM) has a higher fracture risk than the non-diabetic patients, and mesenchymal stem cells (MSCs) from T2DM patients also show a weaker osteogenic potent. The present study aimed to provide a gene expression profile...
Autores principales: | Xia, Sheng-li, Ma, Zi-yuan, Wang, Bin, Gao, Feng, Guo, Sheng-yang, Chen, Xu-han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438120/ https://www.ncbi.nlm.nih.gov/pubmed/36050744 http://dx.doi.org/10.1186/s13018-022-03291-2 |
Ejemplares similares
-
Icariin promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells in patients with osteoporosis and T2DM by upregulating GLI-1
por: Xia, Sheng-li, et al.
Publicado: (2023) -
Self-assembled microtissues loaded with osteogenic MSCs for in vivo bone regeneration
por: Li, Hui, et al.
Publicado: (2022) -
Enhanced bone tissue regeneration of a biomimetic cellular scaffold with co‐cultured MSCs‐derived osteogenic and angiogenic cells
por: Li, Limei, et al.
Publicado: (2019) -
The Myokine Irisin Promotes Osteogenic Differentiation of Dental Bud-Derived MSCs
por: Posa, Francesca, et al.
Publicado: (2021) -
Engineering microdent structures of bone implant surfaces to enhance osteogenic activity in MSCs
por: Li, Sophia, et al.
Publicado: (2016)